The leaders in rare diseases and orphan drug development are gathering today at the 22nd Orphan Drugs & Rare Diseases Global Congress 2024 Americas to discuss strategies and innovations to promote rare diseases product development and commercialization.

One of the topics covered prominently is the scarcity of data on rare diseases and how data, including patient registries, can help with everything from study design to understanding patient outcomes, to patient finding in rare & orphan diseases.

Clinakos Inc., unique capabilities of  Integrated Patient Data™ and Medically Smart AI™ turn the scarcity of data, from a challenge to an opportunity, and even a differentiating strategy for our biopharma clients. Connect with us to learn more about how we are enabling efficacious patient treatment, access, and outcomes through our platform.